A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.
Certis Oncology Solutions, led by Peter Ellman, President and CEO, is a life science technology company dedicated to realizing the promise of precision oncology. The company’s product is Oncology ...
If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of ...